Credit Capital Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

Credit Capital Investments’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-80,000	Closed	-$1.76M	–	41
2018 Q2	$1.76M	Buy	80,000 +5,000	+7%	+$111K	1.58%	20
2018 Q1	$1.51M	Buy	75,000 +30,000	+67%	+$507K	1.43%	20
2017 Q4	$596K	Buy	45,000 +30,000	+200%	+$452K	0.62%	29
2017 Q3	$277K	Hold	15,000	–	–	0.31%	36
2017 Q2	$276K	Buy	15,000 +2,187	+17%	+$43.3K	0.37%	28
2017 Q1	$289K	Sell	12,813 -60,000	-82%	-$1.44M	0.31%	34
2016 Q4	$2.53M	Sell	72,813 -37,000	-34%	-$1.11M	3.24%	9
2016 Q3	$2.69M	Buy	109,813 +80,000	+268%	+$2M	2.84%	12
2016 Q2	$713K	Sell	29,813 -10,000	-25%	-$229K	1.01%	14
2016 Q1	$932K	Buy	39,813 +29,413	+283%	+$698K	0.67%	26
2015 Q4	$314K	Hold	10,400	–	–	0.21%	35
2015 Q3	$413K	Buy	+10,400	New	+$646K	0.28%	31

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Capital Investments's AMAG Position: Q3 2018 in Review

Credit Capital Investments sold out of AMAG Pharmaceuticals (AMAG) in Q3 2018, closing a stake of 80,000 shares — an estimated $1.76M sold.

Credit Capital Investments first reported a position in AMAG in Q3 2015 and held it in 12 quarters. The position peaked at $2.69M in Q3 2016. 182 funds tracked by Wall St. Rank hold AMAG as of Q3 2018.

Credit Capital Investments reported no remaining AMAG Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Credit Capital Investments sold 80,000 AMAG Pharmaceuticals shares in Q3 2018, an estimated $1.76M.
Credit Capital Investments first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 12 quarters.
Credit Capital Investments's AMAG Pharmaceuticals position peaked at $2.69M in Q3 2016.
182 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2018.

Based on Credit Capital Investments's 13F filing for Q3 2018, filed 14 Nov 2018.